The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Commercial Real Estate Slows Again as Investors Flock to Larger, Safer Deals
November marked another cooldown for commercial real estate, with total deal volume dropping 10% year over year and falling below even 2020’s levels. While overall activity is slowing, investors are concentrating their money on bigger, more resilient assets—driving a 51% surge in deals over $100 million and pushing average transaction sizes well above historical norms. Multifamily remains the strongest sector, office deals are becoming more strategically focused, and medical office and data centers continue to outperform as long‑term demand stays solid.
